Hyku Biosciences
PrivateLast Round
Seed
Jul 30, 2026
Total Funding Raised
$64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hyku Biosciences is a biotechnology company that develops small molecule therapeutics with innovative mechanisms designed to effectively inactivate disease-driving proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hyku Biosciences Comparables
Compare Hyku Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexo Therapeutics | 86% | |
| ChomiX Biotech | 81% | |
| KyDo Therapeutics | 81% |
Hyku Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 30, 2026 | ||||
| Seed Round | May 22, 2026 | ||||
| Seed Round | Feb 9, 2026 | ||||
| Seed | Nov 12, 2024 | ||||
| Seed | Sep 19, 2023 |
Hyku Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| KB Investment | Seed |
| KB Investment | Seed |
| Eisai Innovation | Seed |
| Droia Ventures | Seed |
| Chugai Venture Fund | Seed |
| The Mark Foundation for Cancer Research | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Raised $9M in Seed funding.
- Jun 22, 2026
Monthly visitors increased 32% MoM, reaching 2K.
Hyku Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hyku Biosciences's valuation, stock price, and market status.
Is Hyku Biosciences a public or private company?
Hyku Biosciences is a private company.
What is the current stock price of Hyku Biosciences?
Hyku Biosciences is a private company, so its shares have no public market price. Caplight tracks Hyku Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hyku Biosciences worth (valuation)?
Valuation information for Hyku Biosciences is not publicly available.
Can I buy Hyku Biosciences stock?
Hyku Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hyku Biosciences's last funding round?
Hyku Biosciences's most recent funding round was Seed on July 30, 2026.
Who are the main investors in Hyku Biosciences?
Key investors in Hyku Biosciences include RA Capital Management, Droia Ventures, Chugai Venture Fund.
Will Hyku Biosciences IPO soon?
No public IPO plans have been announced for Hyku Biosciences.
How can I track Hyku Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Hyku Biosciences's shares on secondary markets.